These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients. Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935 [TBL] [Abstract][Full Text] [Related]
31. Tumor induced osteomalacia: A single center experience on 17 patients. Crotti C; Bartoli F; Coletto LA; Manara M; Marini E; Daolio PA; Parafioriti A; Armiraglio E; Zucchi F; Sinigaglia L; Caporali R; Varenna M Bone; 2021 Nov; 152():116077. PubMed ID: 34175499 [TBL] [Abstract][Full Text] [Related]
32. Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases. Bosman A; Palermo A; Vanderhulst J; De Beur SMJ; Fukumoto S; Minisola S; Xia W; Body JJ; Zillikens MC Calcif Tissue Int; 2022 Oct; 111(4):367-379. PubMed ID: 35857061 [TBL] [Abstract][Full Text] [Related]
39. [Osteomalacia due to phosphate deficiency caused by a tumor. Focus on FGF23 in physiology and clinic]. Westerberg PA; Linde T; Ljunggren O Lakartidningen; 2012 Aug 8-21; 109(32-33):1414-6. PubMed ID: 22953430 [No Abstract] [Full Text] [Related]